Strata Critical Medical, Inc.
Strata Critical Medical, Inc. (Nasdaq: SRTA) provides time-critical logistics and medical services to the U.S. healthcare industry, serving transplant centers, organ procurement organizations, hospitals and other businesses. Its integrated services support donor-organ recovery and transplantation, including air and… From the company’s description.
Over the twelve months to Sep 30, 2026, Strata Critical Medical, Inc. reported revenue of $280.76M and a net loss of $24.81M. Its operating margin was −6.6%, and operations generated $10.72M in cash. In fiscal 2025, it reported revenue of $197.14M and net income of $41.35M.
Dotted labels explain each measure. is shown separately from the annual figures.
What Strata Critical Medical, Inc. does
In the company’s own words
Strata Critical Medical, Inc. (Nasdaq: SRTA) provides time-critical logistics and medical services to the U.S. healthcare industry, serving transplant centers, organ procurement organizations, hospitals and other businesses. Its integrated services support donor-organ recovery and transplantation, including air and ground transport, organ placement, surgical recovery, normothermic regional perfusion and organ preservation; it also provides cardiac perfusion staffing, blood management, equipment and related services. Strata reports two operating segments: Logistics, marketed under the Trinity brand, and Clinical, marketed under the Keystone brand. Logistics includes transportation and organ placement services, including Trinity Organ Placement Services (TOPS); Clinical covers transplant-related services and perfusion solutions for cardiovascular surgery and other healthcare providers. The company generally uses third-party aircraft operators for air transport and combines owned vehicles with third-party providers for ground transport. Following the 2025 divestiture of its passenger mobility business and acquisition of Keystone, Strata focuses on medical logistics and clinical services. It employed 601 people across the United States as of December 31, 2025. Its website is www.stratacritical.com.
Company details
- Sector
- Industrials
- Industry (SIC)
- Transportation & Utilities
- Headquarters
- NEW YORK, NY
- Fiscal year end
- December
- CIK
- 1779128
- SIC
- 4700
Financial performance, year by year
Fiscal 2019–2025 · USDThe full income statement, balance sheet and cash flow for each of these years — every figure traceable to its filing — is on the Financials tab with a free account.
Who owns Strata Critical Medical, Inc. — and what changed
Funds as of 2026Q2 · superinvestors as of 2026-06-30
Superinvestors in Strata Critical Medical, Inc. · what they did last quarter
Share of each manager’s reported 13F portfolio. Change is in shares held, since the previous quarter.
Largest fund holders · Strata Critical Medical, Inc.’s weight in each
Fund ownership is a floor, not a census — pensions, insurers and people holding shares directly are not visible here.
Fund ownership counts N-PORT filers only, so it is a floor rather than a census — pensions, insurers and direct holders are not visible here, and the remainder is not “held by individuals”.
Fund ownership is a subset of institutional 13F ownership — the two describe overlapping populations and must not be added together.
Could not be determined for this company: bond issues.
Every fund and institutional holder, quarter by quarter, is on the Ownership tab with a free account.
Recent filings
All filings →Each filing opens into its own statements and disclosures here.
Put this business in context.
Compare this company with peers, find it in your funds and follow its financial history with your connected AI:
- “How do Strata Critical Medical, Inc. and its peers compare on margins and cash generation over ten years?”
- “Where did five years of Strata Critical Medical, Inc.'s earnings go — cash, debt, buybacks, reinvestment?”
- “What changed in Strata Critical Medical, Inc.'s last four quarterly filings that the numbers alone won't show?”